These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 22372696)
1. Synthesis, gene silencing, and molecular modeling studies of 4'-C-aminomethyl-2'-O-methyl modified small interfering RNAs. Gore KR; Nawale GN; Harikrishna S; Chittoor VG; Pandey SK; Höbartner C; Patankar S; Pradeepkumar PI J Org Chem; 2012 Apr; 77(7):3233-45. PubMed ID: 22372696 [TBL] [Abstract][Full Text] [Related]
2. Gene silencing activity of siRNAs with a ribo-difluorotoluyl nucleotide. Xia J; Noronha A; Toudjarska I; Li F; Akinc A; Braich R; Frank-Kamenetsky M; Rajeev KG; Egli M; Manoharan M ACS Chem Biol; 2006 Apr; 1(3):176-83. PubMed ID: 17163665 [TBL] [Abstract][Full Text] [Related]
3. Influence of 2'-fluoro versus 2'-O-methyl substituent on the sugar puckering of 4'-C-aminomethyluridine. Gore KR; Harikrishna S; Pradeepkumar PI J Org Chem; 2013 Oct; 78(19):9956-62. PubMed ID: 24016294 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and Biophysical Characterization of RNAs Containing ( R)- and ( S)-5'- C-Aminopropyl-2'- O-methyluridines. Kajino R; Maeda Y; Yoshida H; Yamagishi K; Ueno Y J Org Chem; 2019 Mar; 84(6):3388-3404. PubMed ID: 30807158 [TBL] [Abstract][Full Text] [Related]
5. Molecular structure of the core-modified siRNA duplexes containing diastereomeric pair of [C6'(R)-OH]- versus [C6'(S)-OH]-carba-LNAs suggests a model for RNAi action. Plashkevych O; Chattopadhyaya J Nucleosides Nucleotides Nucleic Acids; 2011 Nov; 30(11):815-25. PubMed ID: 22060548 [TBL] [Abstract][Full Text] [Related]
6. Silencing activity of 2'-O-methyl modified anti-MDR1 siRNAs with mismatches in the central part of the duplexes. Petrova NS; Meschaninova MI; Venyaminova AG; Zenkova MA; Vlassov VV; Chernolovskaya EL FEBS Lett; 2011 Jul; 585(14):2352-6. PubMed ID: 21704032 [TBL] [Abstract][Full Text] [Related]
7. Effects of conformational alteration induced by D-/L-isonucleoside incorporation in siRNA on their stability in serum and silencing activity. Huang Y; Chen Z; Chen Y; Zhang H; Zhang Y; Zhao Y; Yang Z; Zhang L Bioconjug Chem; 2013 Jun; 24(6):951-9. PubMed ID: 23682837 [TBL] [Abstract][Full Text] [Related]
8. Modification of the siRNA passenger strand by 5-nitroindole dramatically reduces its off-target effects. Zhang J; Zheng J; Lu C; Du Q; Liang Z; Xi Z Chembiochem; 2012 Sep; 13(13):1940-5. PubMed ID: 22887813 [TBL] [Abstract][Full Text] [Related]
9. Structural and binding study of modified siRNAs with the Argonaute 2 PAZ domain by NMR spectroscopy. Maiti M; Nauwelaerts K; Lescrinier E; Herdewijn P Chemistry; 2011 Feb; 17(5):1519-28. PubMed ID: 21268154 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and properties of 5-pyrrolyl-cytidine and uridine derivatives. Miyata K; Mineo R; Tamamushi R; Taguchi H; Seio K; Sekine M Nucleic Acids Symp Ser (Oxf); 2004; (48):15-6. PubMed ID: 17150455 [TBL] [Abstract][Full Text] [Related]
11. Effect of Sugar 2',4'-Modifications on Gene Silencing Activity of siRNA Duplexes. Malek-Adamian E; Fakhoury J; Arnold AE; Martínez-Montero S; Shoichet MS; Damha MJ Nucleic Acid Ther; 2019 Aug; 29(4):187-194. PubMed ID: 31084536 [TBL] [Abstract][Full Text] [Related]
12. Design of nuclease-resistant fork-like small interfering RNA (fsiRNA). Chernolovskaya EL; Zenkova MA Methods Mol Biol; 2013; 942():153-68. PubMed ID: 23027050 [TBL] [Abstract][Full Text] [Related]
13. Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing. Harborth J; Elbashir SM; Vandenburgh K; Manninga H; Scaringe SA; Weber K; Tuschl T Antisense Nucleic Acid Drug Dev; 2003 Apr; 13(2):83-105. PubMed ID: 12804036 [TBL] [Abstract][Full Text] [Related]
14. 4'- Gangopadhyay S; Das G; Gupta S; Ghosh A; Bagale SS; Roy PK; Mandal M; Harikrishna S; Sinha S; Gore KR J Org Chem; 2024 Mar; 89(6):3747-3768. PubMed ID: 38394362 [TBL] [Abstract][Full Text] [Related]
15. Solid-phase synthesis of modified RNAs containing amide-linked oligoribonucleosides at their 3'-end and their application to siRNA. Iwase R; Toyama T; Nishimori K Nucleosides Nucleotides Nucleic Acids; 2007; 26(10-12):1451-4. PubMed ID: 18066804 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the RNase H cleavage kinetics and blood serum stability of the north-conformationally constrained and 2'-alkoxy modified oligonucleotides. Honcharenko D; Barman J; Varghese OP; Chattopadhyaya J Biochemistry; 2007 May; 46(19):5635-46. PubMed ID: 17411072 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of 2'-O-guanidinopropyl-modified nucleoside phosphoramidites and their incorporation into siRNAs targeting hepatitis B virus. Brzezinska J; D'Onofrio J; Buff MC; Hean J; Ely A; Marimani M; Arbuthnot P; Engels JW Bioorg Med Chem; 2012 Feb; 20(4):1594-606. PubMed ID: 22264759 [TBL] [Abstract][Full Text] [Related]